Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The heparin-sensitive receptor on dendritic cells is a critical mediator of the high immunogenicity and associated toxicity of Adenovirus serotype 5 (Ad5) viral vectors. Unlike the primary CAR receptor used for epithelial infection, this receptor interacts specifically with the KKTK motif in the Ad5 fiber shaft, allowing the virus to efficiently transduce dendritic cells and initiate potent T-cell and B-cell responses. This pathway is the molecular basis for the effectiveness of many Ad5-based vaccines, including those for COVID-19 and Ebola, but it also triggers the release of pyrogenic cytokines that cause transient fevers in clinical trial participants. While often referred to by its sensitivity to heparin inhibition, the receptor's identity is closely linked to proteins such as DC-SIGN (CD209) and L-selectin (CD62L), which facilitate viral attachment and entry in the absence of traditional receptors. Understanding this interaction is vital for engineering safer, next-generation viral vectors that maintain immunogenicity while minimizing systemic inflammatory side effects.
Binding of the Adenovirus fiber shaft KKTK motif to the receptor facilitates viral entry into dendritic cells, leading to antigen presentation and stimulation of adaptive immunity, while simultaneously triggering pro-inflammatory signaling and pyrogenic responses.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heparin-sensitive receptor on dendritic cells.